Artem Kim,Clara Savary,Christèle Dubourg,Wilfrid Carré,Charlotte Mouden,Houda Hamdi-Rozé,Hélène Guyodo,Jerome Le Douce,Emmanuelle Génin,Dominique Campion,Jean-François Dartigues,Jean-François Deleuze,Jean-Charles Lambert,Richard Redon,Thomas Ludwig,Benjamin Grenier-Boley,Sébastien Letort,Pierre Lindenbaum,Vincent Meyer,Olivier Quenez,Christian Dina,Céline Bellenguez,Camille Charbonnier-Le Clézio,Joanna Giemza,Stéphanie Chatel,Claude Férec,Hervé Le Marec,Luc Letenneur,Gaël Nicolas,Karen Rouault,Delphine Bacq,Anne Boland,Doris Lechner,Cisca Wijmenga,Morris A Swertz,P Eline Slagboom,Gert-Jan B van Ommen,Cornelia M van Duijn,Dorret I Boomsma,Paul I W de Bakker,Jasper A Bovenberg,P Eline Slagboom,Anton J M de Craen,Marian Beekman,Albert Hofman,Dorret I Boomsma,Gonneke Willemsen,Bruce Wolffenbuttel,Mathieu Platteel,Yuanping Du,Ruoyan Chen,Hongzhi Cao,Rui Cao,Yushen Sun,Jeremy Sujie Cao,Morris A Swertz,Freerk van Dijk,Pieter B T Neerincx,Patrick Deelen,Martijn Dijkstra,George Byelas,Alexandros Kanterakis,Jan Bot,Kai Ye,Eric-Wubbo Lameijer,Martijn Vermaat,Jeroen F J Laros,Johan T den Dunnen,Peter de Knijff,Lennart C Karssen,Elisa M van Leeuwen,Najaf Amin,Vyacheslav Koval,Fernando Rivadeneira,Karol Estrada,Jayne Y Hehir-Kwa,Joep de Ligt,Abdel Abdellaoui,Jouke-Jan Hottenga,V Mathijs Kattenberg,David van Enckevort,Hailiang Mei,Mark Santcroos,Barbera D C van Schaik,Robert E Handsaker,Steven A McCarroll,Evan E Eichler,Arthur Ko,Peter Sudmant,Laurent C Francioli,Wigard P Kloosterman,Isaac J Nijman,Victor Guryev,Paul I W de Bakker,Laurent Pasquier,Elisabeth Flori,Marie Gonzales,Claire Bénéteau,Odile Boute,Tania Attié-Bitach,Joelle Roume,Louise Goujon,Linda Akloul,Sylvie Odent,Erwan Watrin,Valérie Dupé,Marie de Tayrac,Véronique David,,

Abstract:Holoprosencephaly is a pathology of forebrain development characterized by high phenotypic heterogeneity. The disease presents with various clinical manifestations at the cerebral or facial levels. Several genes have been implicated in holoprosencephaly but its genetic basis remains unclear: different transmission patterns have been described including autosomal dominant, recessive and digenic inheritance. Conventional molecular testing approaches result in a very low diagnostic yield and most cases remain unsolved. In our study, we address the possibility that genetically unsolved cases of holoprosencephaly present an oligogenic origin and result from combined inherited mutations in several genes. Twenty-six unrelated families, for whom no genetic cause of holoprosencephaly could be identified in clinical settings [whole exome sequencing and comparative genomic hybridization (CGH)-array analyses], were reanalysed under the hypothesis of oligogenic inheritance. Standard variant analysis was improved with a gene prioritization strategy based on clinical ontologies and gene co-expression networks. Clinical phenotyping and exploration of cross-species similarities were further performed on a family-by-family basis. Statistical validation was performed on 248 ancestrally similar control trios provided by the Genome of the Netherlands project and on 574 ancestrally matched controls provided by the French Exome Project. Variants of clinical interest were identified in 180 genes significantly associated with key pathways of forebrain development including sonic hedgehog (SHH) and primary cilia. Oligogenic events were observed in 10 families and involved both known and novel holoprosencephaly genes including recurrently mutated FAT1, NDST1, COL2A1 and SCUBE2. The incidence of oligogenic combinations was significantly higher in holoprosencephaly patients compared to two control populations (P < 10-9). We also show that depending on the affected genes, patients present with particular clinical features. This study reports novel disease genes and supports oligogenicity as clinically relevant model in holoprosencephaly. It also highlights key roles of SHH signalling and primary cilia in forebrain development. We hypothesize that distinction between different clinical manifestations of holoprosencephaly lies in the degree of overall functional impact on SHH signalling. Finally, we underline that integrating clinical phenotyping in genetic studies is a powerful tool to specify the clinical relevance of certain mutations.

Genetic Insights Into Hypothalamic Hamartoma: Unraveling Somatic Variants

Author Correction: Failure of Human Rhombic Lip Differentiation Underlies Medulloblastoma Formation

Somatic Variants in New Candidate Genes Identified in Focal Cortical Dysplasia Type II

Hypothalamic hamartoma: Epileptogenesis beyond the lesion?

Advances in epileptic network findings of hypothalamic hamartomas

Somatic variants as a cause of drug‐resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis

Multimodal Approach for the Treatment of Complex Hypothalamic Hamartomas

Detection of brain somatic variation in epilepsy-associated developmental lesions

Clinical spectrum and difficulties in management of hypothalamic hamartoma in a developing country

Integrated clinical and omics approach to rare diseases: novel genes and oligogenic inheritance in holoprosencephaly

Contribution of Somatic Ras/Raf/MAPK Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy

Advances in hypothalamic hamartoma research over the past 30 years (1992–2021): a bibliometric analysis

Classification of Hypothalamic Hamartoma and Prognostic Factors for Surgical Outcome.

Epilepsy in hypothalamic hamartomas: semiology spectrum and predictor analyses of 78 patients

Somatic variant analysis of resected brain tissue in epilepsy surgery patients

Mono and biallelic variants in cause severe neurodevelopmental disorders

Neuroimaging appearance of hypothalamic hamartomas in monozygotic twins with Pallister-Hall syndrome: case report and review of the literature

A Rare Cause of Epilepsy: Hypothalamic Hamartoma

Functional characterization of sonic hedgehog mutations associated with holoprosencephaly

Classification of hypothalamic hamartoma according to the clinical manifestations of 214 cases

Clinical characteristics and molecular genetic analysis of a cohort with idiopathic congenital hypogonadism